ProQR Therapeutics Announces Annual Shareholder Meeting
LEIDEN, the Netherlands, April 29, 2015 (GLOBE NEWSWIRE) -- ProQR Therapeutics N.V. (Nasdaq:PRQR), today announced that the Annual General Meeting of Shareholders will be held on Wednesday, June 10, 2015 at 16:00 CET, at Naturalis Biodiversity Center at Darwinweg 2, 2333 CR Leiden, the Netherlands.
All relevant documents and information for the meeting including the notice, agenda and webcast information are or will be made available in the "Investor Relations" section of ProQR's website (Internal linkwww.proqr.com). It is also available on the SEC's website at External linkwww.sec.gov (external link).
About ProQR
ProQR Therapeutics is dedicated to changing lives through the creation of transformative RNA medicines for the treatment of severe diseases such as cystic fibrosis and Leber's congenital amaurosis. Based on our unique proprietary RNA repair platform technologies we are growing our pipeline with patients and loved ones in mind. Since 2012.
ProQR Therapeutics N.V.:
Smital Shah
Chief Financial Officer
T: +1 415 231 6431
Internal linkir@proqr.com
Media inquiries:
Gretchen Schweitzer
MacDougall Biomedical Communications
Direct: +49 172 861 8540
Main: +49 89 2424 3494
Internal linkgschweitzer@macbiocom.com
